Cargando…
SARS‐CoV‐2 neutralizing antibodies decline over one year and patients with severe COVID‐19 pneumonia display a unique cytokine profile
OBJECTIVES: As coronavirus disease 2019 (COVID-19) rages on worldwide, there is an urgent need to characterize immune correlates of protection from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and to identify immune determinants of COVID-19 severity. METHODS: This study exa...
Autores principales: | Vacharathit, Vimvara, Srichatrapimuk, Sirawat, Manopwisedjaroen, Suwimon, Kirdlarp, Suppachok, Srisaowakarn, Chanya, Setthaudom, Chavachol, Inrueangsri, Nanthicha, Pisitkun, Prapaporn, Kunakorn, Mongkol, Hongeng, Suradej, Sungkanuparph, Somnuek, Thitithanyanont, Arunee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442529/ https://www.ncbi.nlm.nih.gov/pubmed/34536610 http://dx.doi.org/10.1016/j.ijid.2021.09.021 |
Ejemplares similares
-
CoronaVac induces lower neutralising activity against variants of concern than natural infection
por: Vacharathit, Vimvara, et al.
Publicado: (2021) -
SARS-CoV-2 RT-PCR positivity of individuals subsequent to completing quarantine upon entry into a country during a transmission-free period
por: Srichatrapimuk, Sirawat, et al.
Publicado: (2022) -
Detectable Duration of Viable SARS-CoV-2, Total and Subgenomic SARS-CoV-2 RNA in Noncritically Ill COVID-19 Patients: a Prospective Cohort Study
por: Phuphuakrat, Angsana, et al.
Publicado: (2022) -
Mice Immunized with the Vaccine Candidate HexaPro Spike Produce Neutralizing Antibodies against SARS-CoV-2
por: Seephetdee, Chotiwat, et al.
Publicado: (2021) -
Integrated therapy for HIV and cryptococcosis
por: Srichatrapimuk, Sirawat, et al.
Publicado: (2016)